AHMED NADIM 4
4 · Cullinan Oncology, Inc. · Filed Jul 5, 2022
Insider Transaction Report
Form 4
AHMED NADIM
DirectorPresident and CEO
Transactions
- Award
Common Stock
2022-06-30$10.90/sh+1,620$17,658→ 9,710 total
Footnotes (2)
- [F1]The reporting person is voluntarily reporting the acquisition of shares of the Issuer's common stock pursuant to the Issuer's 2021 Employee Stock Purchase Plan (the "ESPP"), for the purchase period of January 1, 2022 through June 30, 2022. This transaction is also exempt under Rule 16b-3(c).
- [F2]In accordance with the ESPP, the shares were purchased based on 85% of the closing price of the Issuer's common stock on June 30, 2022.